Protara Therapeutics, Inc. Shareholders' Equity
Protara Therapeutics, Inc. (TARA) had Shareholders' Equity of $161.31 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $161.31M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $181.21M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $196.41M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $132.29M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $161.31M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $181.21M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $196.41M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $132.29M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $144.42M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $158.48M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $167.13M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $81.79M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $92.05M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $58.41M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $68.32M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $76.96M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $85.22M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $94.77M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $102.08M 10-K · filed 2025-03-05 | |
| 2022-09-30 | $139.18M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $145.46M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $152.24M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $161.91M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $170.41M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $178.41M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $188.13M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $199.24M 10-K · filed 2023-03-08 | |
| 2020-09-30 | $194.63M 10-Q · filed 2021-11-04 | $194.63M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $59.43M 10-Q · filed 2021-11-04 | $59.43M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $64.74M 10-Q · filed 2021-11-04 | $64.74M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$2.13M 10-K · filed 2022-03-09 | $6.39M 10-K · filed 2020-03-20 |
| 2019-09-30 | $284.91K 10-Q · filed 2020-11-12 | $8.04M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $2.00M 10-Q · filed 2020-11-12 | $9.48M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.33M 10-Q · filed 2020-11-12 | $14.69M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $4.78M 10-K · filed 2021-03-11 | $20.44M 10-K · filed 2019-03-13 |
| 2018-09-30 | $24.87M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $25.62M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $29.49M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $34.74M 10-K · filed 2020-03-20 | $34.74M 10-K · filed 2018-03-14 |
| 2017-09-30 | $39.47M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $29.49M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $33.00M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $38.44M 10-K · filed 2019-03-13 | |
| 2016-09-30 | $44.45M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $50.92M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $57.75M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $63.41M 10-K · filed 2019-03-13 | |
| 2015-09-30 | $69.03M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $73.76M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $78.29M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $82.46M 10-K · filed 2018-03-14 | |
| 2014-09-30 | -$116.55M 10-Q · filed 2014-11-25 | |
| 2013-12-31 | -$100.51M 10-K · filed 2017-03-16 | |
| 2012-12-31 | -$86.66M 10-K · filed 2016-03-14 | |
| 2011-12-31 | -$72.66M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |